[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global RNA-based Biopharmaceuticals Market Research Report 2017

July 2017 | 110 pages | ID: G7017DD34C6EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global RNA-based Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of RNA-based Biopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Global RNA-based Biopharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals
  • Benitec Biopharma
  • Calimmune Inc
  • Dicerna
  • Gradalis
  • Quark
  • RXi
  • Senesco
  • Silence Therapeutics
  • Silenseed
  • Tekmira
  • Alnylam Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Therapeutics
  • Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of RNA-based Biopharmaceuticals for each application, including
  • Cancer
  • Diabetes
  • Tuberculosis
  • Cardiovascular Diseases
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global RNA-based Biopharmaceuticals Market Research Report 2017

1 RNA-BASED BIOPHARMACEUTICALS MARKET OVERVIEW

1.1 Product Overview and Scope of RNA-based Biopharmaceuticals
1.2 RNA-based Biopharmaceuticals Segment by Type (Product Category)
  1.2.1 Global RNA-based Biopharmaceuticals Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global RNA-based Biopharmaceuticals Production Market Share by Type (Product Category) in 2016
  1.2.3 Therapeutics
  1.2.4 Vaccines
1.3 Global RNA-based Biopharmaceuticals Segment by Application
  1.3.1 RNA-based Biopharmaceuticals Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Global RNA-based Biopharmaceuticals Market by Region (2012-2022)
  1.4.1 Global RNA-based Biopharmaceuticals Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of RNA-based Biopharmaceuticals (2012-2022)
  1.5.1 Global RNA-based Biopharmaceuticals Revenue Status and Outlook (2012-2022)
  1.5.2 Global RNA-based Biopharmaceuticals Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL RNA-BASED BIOPHARMACEUTICALS MARKET COMPETITION BY MANUFACTURERS

2.1 Global RNA-based Biopharmaceuticals Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global RNA-based Biopharmaceuticals Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global RNA-based Biopharmaceuticals Production and Share by Manufacturers (2012-2017)
2.2 Global RNA-based Biopharmaceuticals Revenue and Share by Manufacturers (2012-2017)
2.3 Global RNA-based Biopharmaceuticals Average Price by Manufacturers (2012-2017)
2.4 Manufacturers RNA-based Biopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type
2.5 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
  2.5.1 RNA-based Biopharmaceuticals Market Concentration Rate
  2.5.2 RNA-based Biopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL RNA-BASED BIOPHARMACEUTICALS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global RNA-based Biopharmaceuticals Capacity and Market Share by Region (2012-2017)
3.2 Global RNA-based Biopharmaceuticals Production and Market Share by Region (2012-2017)
3.3 Global RNA-based Biopharmaceuticals Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL RNA-BASED BIOPHARMACEUTICALS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global RNA-based Biopharmaceuticals Consumption by Region (2012-2017)
4.2 North America RNA-based Biopharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.3 Europe RNA-based Biopharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.4 China RNA-based Biopharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.5 Japan RNA-based Biopharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia RNA-based Biopharmaceuticals Production, Consumption, Export, Import (2012-2017)
4.7 India RNA-based Biopharmaceuticals Production, Consumption, Export, Import (2012-2017)

5 GLOBAL RNA-BASED BIOPHARMACEUTICALS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global RNA-based Biopharmaceuticals Production and Market Share by Type (2012-2017)
5.2 Global RNA-based Biopharmaceuticals Revenue and Market Share by Type (2012-2017)
5.3 Global RNA-based Biopharmaceuticals Price by Type (2012-2017)
5.4 Global RNA-based Biopharmaceuticals Production Growth by Type (2012-2017)

6 GLOBAL RNA-BASED BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION

6.1 Global RNA-based Biopharmaceuticals Consumption and Market Share by Application (2012-2017)
6.2 Global RNA-based Biopharmaceuticals Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL RNA-BASED BIOPHARMACEUTICALS MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pfizer RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Roche RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Sanofi-Aventis
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Arrowhead Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Benitec Biopharma
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Calimmune Inc
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Calimmune Inc RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Dicerna
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Dicerna RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Gradalis
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Gradalis RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Quark
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Quark RNA-based Biopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 RXi
7.12 Senesco
7.13 Silence Therapeutics
7.14 Silenseed
7.15 Tekmira
7.16 Alnylam Pharmaceuticals

8 RNA-BASED BIOPHARMACEUTICALS MANUFACTURING COST ANALYSIS

8.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 RNA-based Biopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL RNA-BASED BIOPHARMACEUTICALS MARKET FORECAST (2017-2022)

12.1 Global RNA-based Biopharmaceuticals Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global RNA-based Biopharmaceuticals Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global RNA-based Biopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global RNA-based Biopharmaceuticals Price and Trend Forecast (2017-2022)
12.2 Global RNA-based Biopharmaceuticals Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America RNA-based Biopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe RNA-based Biopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China RNA-based Biopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan RNA-based Biopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia RNA-based Biopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India RNA-based Biopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global RNA-based Biopharmaceuticals Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global RNA-based Biopharmaceuticals Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of RNA-based Biopharmaceuticals
Figure Global RNA-based Biopharmaceuticals Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global RNA-based Biopharmaceuticals Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Therapeutics
Table Major Manufacturers of Therapeutics
Figure Product Picture of Vaccines
Table Major Manufacturers of Vaccines
Figure Global RNA-based Biopharmaceuticals Consumption (K Units) by Applications (2012-2022)
Figure Global RNA-based Biopharmaceuticals Consumption Market Share by Applications in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global RNA-based Biopharmaceuticals Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure China RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global RNA-based Biopharmaceuticals Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global RNA-based Biopharmaceuticals Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global RNA-based Biopharmaceuticals Major Players Product Capacity (K Units) (2012-2017)
Table Global RNA-based Biopharmaceuticals Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global RNA-based Biopharmaceuticals Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global RNA-based Biopharmaceuticals Capacity (K Units) of Key Manufacturers in 2016
Figure Global RNA-based Biopharmaceuticals Capacity (K Units) of Key Manufacturers in 2017
Figure Global RNA-based Biopharmaceuticals Major Players Product Production (K Units) (2012-2017)
Table Global RNA-based Biopharmaceuticals Production (K Units) of Key Manufacturers (2012-2017)
Table Global RNA-based Biopharmaceuticals Production Share by Manufacturers (2012-2017)
Figure 2016 RNA-based Biopharmaceuticals Production Share by Manufacturers
Figure 2017 RNA-based Biopharmaceuticals Production Share by Manufacturers
Figure Global RNA-based Biopharmaceuticals Major Players Product Revenue (Million USD) (2012-2017)
Table Global RNA-based Biopharmaceuticals Revenue (Million USD) by Manufacturers (2012-2017)
Table Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2012-2017)
Table 2016 Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers
Table 2017 Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers
Table Global Market RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers RNA-based Biopharmaceuticals Manufacturing Base Distribution and Sales Area
Table Manufacturers RNA-based Biopharmaceuticals Product Category
Figure RNA-based Biopharmaceuticals Market Share of Top 3 Manufacturers
Figure RNA-based Biopharmaceuticals Market Share of Top 5 Manufacturers
Table Global RNA-based Biopharmaceuticals Capacity (K Units) by Region (2012-2017)
Figure Global RNA-based Biopharmaceuticals Capacity Market Share by Region (2012-2017)
Figure Global RNA-based Biopharmaceuticals Capacity Market Share by Region (2012-2017)
Figure 2016 Global RNA-based Biopharmaceuticals Capacity Market Share by Region
Table Global RNA-based Biopharmaceuticals Production by Region (2012-2017)
Figure Global RNA-based Biopharmaceuticals Production (K Units) by Region (2012-2017)
Figure Global RNA-based Biopharmaceuticals Production Market Share by Region (2012-2017)
Figure 2016 Global RNA-based Biopharmaceuticals Production Market Share by Region
Table Global RNA-based Biopharmaceuticals Revenue (Million USD) by Region (2012-2017)
Table Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2012-2017)
Figure Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2012-2017)
Table 2016 Global RNA-based Biopharmaceuticals Revenue Market Share by Region
Figure Global RNA-based Biopharmaceuticals Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global RNA-based Biopharmaceuticals Consumption (K Units) Market by Region (2012-2017)
Table Global RNA-based Biopharmaceuticals Consumption Market Share by Region (2012-2017)
Figure Global RNA-based Biopharmaceuticals Consumption Market Share by Region (2012-2017)
Figure 2016 Global RNA-based Biopharmaceuticals Consumption (K Units) Market Share by Region
Table North America RNA-based Biopharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe RNA-based Biopharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table China RNA-based Biopharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan RNA-based Biopharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia RNA-based Biopharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table India RNA-based Biopharmaceuticals Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global RNA-based Biopharmaceuticals Production (K Units) by Type (2012-2017)
Table Global RNA-based Biopharmaceuticals Production Share by Type (2012-2017)
Figure Production Market Share of RNA-based Biopharmaceuticals by Type (2012-2017)
Figure 2016 Production Market Share of RNA-based Biopharmaceuticals by Type
Table Global RNA-based Biopharmaceuticals Revenue (Million USD) by Type (2012-2017)
Table Global RNA-based Biopharmaceuticals Revenue Share by Type (2012-2017)
Figure Production Revenue Share of RNA-based Biopharmaceuticals by Type (2012-2017)
Figure 2016 Revenue Market Share of RNA-based Biopharmaceuticals by Type
Table Global RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2012-2017)
Figure Global RNA-based Biopharmaceuticals Production Growth by Type (2012-2017)
Table Global RNA-based Biopharmaceuticals Consumption (K Units) by Application (2012-2017)
Table Global RNA-based Biopharmaceuticals Consumption Market Share by Application (2012-2017)
Figure Global RNA-based Biopharmaceuticals Consumption Market Share by Applications (2012-2017)
Figure Global RNA-based Biopharmaceuticals Consumption Market Share by Application in 2016
Table Global RNA-based Biopharmaceuticals Consumption Growth Rate by Application (2012-2017)
Figure Global RNA-based Biopharmaceuticals Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Pfizer RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Pfizer RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Roche RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Roche RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Arrowhead Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Benitec Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Benitec Biopharma RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Calimmune Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Calimmune Inc RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Calimmune Inc RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Calimmune Inc RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Dicerna Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Dicerna RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Dicerna RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Gradalis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gradalis RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Gradalis RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Gradalis RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Quark Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark RNA-based Biopharmaceuticals Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA-based Biopharmaceuticals Production Growth Rate (2012-2017)
Figure Quark RNA-based Biopharmaceuticals Production Market Share (2012-2017)
Figure Quark RNA-based Biopharmaceuticals Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA-based Biopharmaceuticals
Figure Manufacturing Process Analysis of RNA-based Biopharmaceuticals
Figure RNA-based Biopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of RNA-based Biopharmaceuticals
Table Distributors/Traders List
Figure Global RNA-based Biopharmaceuticals Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global RNA-based Biopharmaceuticals Price (Million USD) and Trend Forecast (2017-2022)
Table Global RNA-based Biopharmaceuticals Production (K Units) Forecast by Region (2017-2022)
Figure Global RNA-based Biopharmaceuticals Production Market Share Forecast by Region (2017-2022)
Table Global RNA-based Biopharmaceuticals Consumption (K Units) Forecast by Region (2017-2022)
Figure Global RNA-based Biopharmaceuticals Consumption Market Share Forecast by Region (2017-2022)
Figure North America RNA-based Biopharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America RNA-based Biopharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe RNA-based Biopharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe RNA-based Biopharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China RNA-based Biopharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China RNA-based Biopharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan RNA-based Biopharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan RNA-based Biopharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia RNA-based Biopharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia RNA-based Biopharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India RNA-based Biopharmaceuticals Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India RNA-based Biopharmaceuticals Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global RNA-based Biopharmaceuticals Production (K Units) Forecast by Type (2017-2022)
Figure Global RNA-based Biopharmaceuticals Production (K Units) Forecast by Type (2017-2022)
Table Global RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Type (2017-2022)
Table Global RNA-based Biopharmaceuticals Price Forecast by Type (2017-2022)
Table Global RNA-based Biopharmaceuticals Consumption (K Units) Forecast by Application (2017-2022)
Figure Global RNA-based Biopharmaceuticals Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


More Publications